Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
What is CIDP?
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder that causes inflammation of your body’s nerves. Though your immune system generally keeps you healthy by fighting off germs, with CIDP, your immune system does not recognize parts of your nerves and attacks them.
Specifically, the immune system mistakenly attacks your nerves’ protective myelin. When the myelin is damaged or removed, messages transmitted to and from the brain are disrupted and may never make it to their final destination.
Over time, this may cause gradual weakness, numbness and a loss of feeling in your arms and legs. If left untreated, CIDP can cause permanent damage to the nerves.
What is myelin?
Nerves are responsible for sending messages to and from the brain, like when you want your hand to grasp an object or when your hand tells your brain the stove is hot. Healthy nerves are wrapped in a sheath called myelin, much like electric wires wrapped in rubber insulation. The insulation allows electric impulses to travel efficiently along.
Living with CIDP
Elizabeth Thirtyacre is living with chronic inflammatory demyelinating polyneuropathy, also known as CIDP. The rare neurological disorder can cause muscle and nerve damage and lead to pain and weakness among other symptoms. She advises patients like her to listen to their body.
Watch Elizabeth's tipsHere is a sampling of our Vita stories on CIDP:
To read all of our stories, please visit our Vita homepage.
When Common Symptoms Aren’t So Common
Weakness, numbness and tingling in the arms and legs may be signs of CIDP.
From a Living Room to 46 Countries
Award winner Estelle Benson reflects on 35 years of the GBS/CIDP Foundation.
Safeguarding the Rights of a Vulnerable Population
NORD celebrates 35 years of advocating for people with rare diseases.
Resources for you
| RESOURCE | DESCRIPTION | ||
| GBS/CIDP Foundation International | Global non-profit organization supporting individuals and families affected by GBS, CIDP, or related syndromes such as MMN. | View Website | |
| National Organization of Rare Disorders (NORD) | CIDP overview from a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. | View Website |
Treatments Available
Availability of treatments may vary from country to country. Please be sure to visit your local CSLBehring.com site for further information.
| Privigen® | Immune Globulin Intravenous (Human) 10% Liquid | Visit Website | |
| Hizentra® | Immune Globulin Subcutaneous (Human) 20% Liquid | Visit Website |
Participate in Clinical Trials
Discover what is involved in participating in one of our clinical trials and how you can enroll.
Learn More